Biological effect of azacitidine (CC-486) on diffuse large B-cell lymphoma
Ontology highlight
ABSTRACT: Biomarker study for a phase 1, Open-Label, multicenter trial of azacitidine (CC-486) plus R-CHOP in subjects with high-risk previously untreated diffuse large B-cell lymphoma
ORGANISM(S): Homo sapiens
PROVIDER: GSE157302 | GEO | 2022/06/29
REPOSITORIES: GEO
ACCESS DATA